eProtocol Automation
From Synopsis to a Compliant Clinical Trial Protocol Draft in Minutes
Clinion eProtocol is an AI-powered clinical trial protocol authoring software that turns a study synopsis into a structured protocol draft, with medical writers in control of every edit, review, and approval.
- ICH M11 & TransCelerate-aligned
- Human review at every step
- Secure & audit-ready
The Problem
Why Clinical Trial Protocol Development Takes Weeks
A synopsis captures a study’s intent, but turning it into a complete, operational protocol through traditional clinical trial protocol development can take weeks. The work spreads across documents, systems, and teams, and most of that time goes to coordination and rework, not to the scientific thinking itself.
8-12 Weeks
to draft
a clinical protocol
60%
of drafts need
significant revision
3-5
review cycles
before approval
Automate Clinical Trial Protocol Drafting, Not the Expertise
From a single synopsis, Clinion eProtocol uses automated protocol generation to produce a structured first draft in minutes, aligned with ICH M11, TransCelerate, or your sponsor templates. From there, authors and reviewers refine the document together in one place, with consistency checks running across every section.
“Most effort is not spent writing. Most effort is spent resolving ambiguity.”AI handles
- Information retrieval
- Version reconciliation
- Consistency checks
- Drafting and assembly
People keep
- Scientific judgment
- Regulatory accountability
- Stakeholder alignment
- Final approval
How It Works
Four Steps from Study Synopsis to Clinical Trial Protocol Export
Study Setup
Upload your synopsis and supporting documents. The AI extracts the key study details to work from.
AI Authoring
Generate a complete, section-by-section first draft from your source documents.
Review & Refine
Authors and reviewers edit, comment, and resolve AI-flagged recommendations together, with a complete revision history.
Protocol Export
Finalize and export a publication-ready protocol as a formatted Word document.
Human-in-the-loop callout: AI moves the draft forward. A person decides when it’s done, and every edit is captured in a full audit trail.
Built for AI Protocol Authoring
A Layered AI Architecture for Clinical Trial Protocol Automation
Clinion eProtocol uses a layered architecture for clinical trial protocol automation, keeping study documents isolated, your outputs traceable, and specialized AI agents doing the drafting work. Each layer has a job, and security sits under all of it. Inside the agent layer, six specialized agents own a step of the work.
Section Applicability Agent
Identifies the protocol sections your study needs from the synopsis. You approve or adjust each recommendation before drafting begins.
Authoring Agent
Generates structured content with consistent terminology across the entire protocol.
Reviewing Agent
Checks the draft against protocol-writing and regulatory standards, with a complete audit trail.
Impact Analysis Agent
Identifies the protocol sections your study needs from the synopsis. You approve or adjust each recommendation before drafting begins.
Regeneration Impact Agent
Detects downstream impacts when content is regenerated from edits or updated source documents.
Citation Agent
Creates clickable, traceable references in the exported protocol.
The Benefits
What your team gets back
Less time on manual drafting and reconciliation means more time on the science, without giving up control or traceability.
Faster first draft
The authoring agent produces a complete, structured draft in minutes, turning weeks of drafting into a starting point you refine.
Built-in QC
Automated review checks ICH GCP and GDP alignment as you go, reducing the burden of a full manual review pass.
Evidence-backed content
Integrated literature retrieval helps ensure your protocol references relevant scientific evidence, not just internal assumptions.
Writer empowerment
Medical writers focus on judgment and oversight while the AI handles the time-consuming drafting and assembly.
Iterative refinement
Prompt-driven edits let you revise targeted sections without restarting the draft from scratch.
Audit-ready export
Every version exports with references, hyperlinks, and a full edit audit trail intact.
Security and Compliance
Your data stays isolated. Your team stays in control
Adopting AI in a regulated workflow raises fair questions about data, oversight, and accountability. Clinion eProtocol is built to answer them, so faster protocol development never comes at the expense of compliance.
Clear governance
AI supports protocol development within defined boundaries, while medical writers stay responsible for review and final approval.
Data protection
Your study data is isolated per project, with controlled storage, retention, and access, so information from one study never bleeds into another.
Regulatory readiness
Documentation and audit trails capture AI-assisted drafting, review, and revisions, keeping your work aligned with GCP, GDP, and evolving standards.
Security controls
Study documents are protected through role-based access, enterprise authentication, encryption, and audit logging.
Traditional Protocol Authoring vs Clinion eProtocol Software
What changes, and what stays human
Here’s what shifts, and what stays exactly where it should.
| Capability | Traditional authoring | Clinion eProtocol |
|---|
| Capability | Traditional authoring |
|---|
Interactive Demo
Explore Clinion eProtocol Software
Take a guided tour through our end-to-end workflow from each key perspective. See how Admins effortlessly set up projects and manage users, while a Medical Writer uses AI to instantly generate a structured protocol draft. Then, step into the Reviewer’s role to add inline comments, track revisions, and approve content, creating a seamless collaborative cycle that produces a compliant, submission-ready protocol faster than ever.
FAQS
Frequently Asked Questions
Discover quick solutions to your Clinion eProtocol platform queries
Clinion eProtocol is an AI-powered protocol authoring platform that generates a structured, compliant first draft directly from a study synopsis, allowing medical writers to begin from a substantive starting point rather than a blank document.
The platform generates content aligned to ICH M11, TransCelerate, or an organization's own sponsor templates, and applies automated checks for GCP and GDP alignment throughout the drafting process rather than as a separate post-hoc review step.
Clinion eProtocol uses a set of specialized agents, each responsible for a discrete function: identifying applicable protocol sections, generating structured content, reviewing drafts against regulatory standards, assessing the impact of edits or regeneration, and generating traceable citations. This division of labor keeps each stage of drafting auditable and controllable.
By running consistency checks and regulatory alignment checks continuously during drafting, Clinion eProtocol is designed to reduce the rework typically caused by inconsistencies discovered late in the review process, rather than eliminating review itself.
When a section is edited or regenerated, the Regeneration Impact Agent identifies any downstream sections affected by that change, allowing reviewers to address inconsistencies proactively rather than during final approval.
Medical writers and reviewers retain full authority over scientific judgment, regulatory accountability, and final approval. AI-generated content functions as a recommendation that must be reviewed and accepted, with every decision recorded in an audit trail.
Clinion eProtocol isolates study data on a per-project basis, with access governed by role-based permissions, enterprise authentication, and encryption, ensuring no data is shared across studies.
The workflow concludes with a publication-ready protocol exported as a formatted Word document, including hyperlinked citations and a complete audit trail of all edits and AI-assisted contributions.
Still have questions?
Explore how Clinion AI can accelerate your trial – reach out to our team.
Responsible AI
Clinion follows Responsible AI principles, ensuring its AI tools are built for safety and reliability, and remains committed to Data Privacy and Security at every step.
- Accountability
- Transparency
- Privacy & Security
- Reliability & Safety
- Fairness
Unlock the Future of Clinical Trials with Clinion.
Cut your trial costs by 35% and accelerate your time-to-market by 30%
Compliance
Fully Compliant with Global Standards
